HIV & AIDS

Treatment strategy may lead to HIV cure

Armed with a novel strategy they developed for bolstering the body's immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional ...

HIV & AIDS

Among persons with HIV, more finish short-course TB prophylaxis

(HealthDay)—Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy, according to a study published ...

HIV & AIDS

Advancing the long-term well-being of people living with HIV

Since antiretroviral therapy (ART) for HIV was introduced in 1996, AIDS-related morbidity and mortality has declined significantly. People living with HIV are now expected to live nearly as long as people without HIV. Despite ...

HIV & AIDS

UN optimistic on conquering AIDS by 2030

Forty years on since the first AIDS cases were reported, the United Nations said Thursday it was cautiously optimistic that the human immunodeficiency virus (HIV)—the virus that causes the disease—could be beaten by 2030.

HIV & AIDS

The state of HIV screening, diagnosis and treatment in the U.S.

In a new feature in the New England Journal of Medicine, Michael Saag, M.D., professor with the University of Alabama at Birmingham Division of Infectious Diseases and director of the UAB Center for AIDS Research, details ...

page 12 from 40